900
Participants
Start Date
February 28, 2018
Primary Completion Date
May 9, 2018
Study Completion Date
May 22, 2019
YF-17D
YF-17D SC injection.
TDV
TDV SC injection.
Placebo
Normal Saline (0.9% NaCl) SC injection.
Regional Clinical Research Inc., Endwell
Clinical Research Associates of Tidewater, Norfolk
Coastal Clinical Research Inc, Mobile
Rapid Medical Research Inc, Cleveland
Center for Pharmaceutical Research, Kansas City
Johnson County Clin-Trials, Lenexa
Meridian Clinical Research LLC, Omaha
Tekton Research, Austin
Advanced Clinical Research, Meridian
Advanced Clinical Research, West Jordan
Empire Clinical Research, Pomona
Lead Sponsor
Takeda
INDUSTRY